NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹4.00 Cr | ₹3.23 Cr | ₹2.70 Cr | ₹2.55 Cr | ₹2.46 Cr |
What is the latest Long Term Provisions ratio of NGL FINECHEM ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹4.00 Cr |
| Mar2024 | ₹3.23 Cr |
| Mar2023 | ₹2.70 Cr |
| Mar2022 | ₹2.55 Cr |
| Mar2021 | ₹2.46 Cr |
How is Long Term Provisions of NGL FINECHEM Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.00 Cr | 24.02 | |
| Mar2024 | ₹3.23 Cr | 19.30 | |
| Mar2023 | ₹2.70 Cr | 6.04 | |
| Mar2022 | ₹2.55 Cr | 3.62 | |
| Mar2021 | ₹2.46 Cr | - | |
Compare Long Term Provisions of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,683.2 Cr | -0.7% | 23.6% | 161.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -0.7% |
23.6% |
161.6% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses